「Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement<Abstract of dissertation>」の関連論文
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
-
Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
-
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma
-
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma
-
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing (本文)
-
外科的に切除された膵癌におけるST2発現の臨床病理学的及び予後との関連性の検討
-
Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis
-
Effect of Radiotherapy after Breast-conserving Surgery in Elderly Patients with Early Breast Cancer according to the American Joint Committee on Cancer 8th Edition Breast Cancer Staging System in Japan
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
-
Clinical and Basic Research for Ovarian Cancer
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
-
Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Preclinical Evaluation of Lymph Node Targeted Therapy in Mouse Models of Cancer
-
Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas : long-term results
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
-
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Molecular biological analysis of 5-FU-resistant gastric cancer organoids: KHDRBS3 contributes to the attainment of features of cancer stem cell
-
Molecular biological analysis of 5-FU-resistant gastric cancer organoids: KHDRBS3 contributes to the attainment of features of cancer stem cell
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
-
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder
-
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
Efficacious Combination Drug Treatment for Colorectal Cancer that Overcomes Resistance to KRAS G12C Inhibitors
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
-
セツキシマブ併用放射線治療中にニューモシスチス肺炎を発症し,診断に苦慮した1例
-
Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma
-
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer